DESIPRAMINE TREATMENT FOR COCAINE DEPENDENCE IN BUPRENORPHINE- OR METHADONE-TREATED PATIENTS: BASELINE URINE RESULTS AS PREDICTOR OF RESPONSE

Lignende værker

• DESIPRAMINE AND CONTINGENCY MANAGEMENT FOR COCAINE AND OPIATE DEPENDENCE IN BUPRENORPHINE MAINTAINED PATIENTS
  af: KOSTEN, T.
• DEPRESSION PREDICTS HIGHER RATES OF HEROIN USE ON DESIPRAMINE WITH BUPRENORPHINE THAN WITH METHADONE
  af: KOSTEN, T.
• EFFECTS OF REDUCING CONTINGENCY MANAGEMENT VALUES ON HEROIN AND COCAINE USE FOR BUPRENORPHINE- AND DESIPRAMINE-TREATED PATIENTS
  af: KOSTEN, T.
• DESIPRAMINE, AMANTADINE, OR FLUOXETINE IN BUPRENORPHINE-MAINTAINED COCAINE USERS
  af: OLIVETO, A.
• TIAGABINE INCREASES COCAINE-FREE URINES IN COCAINE-DEPENDENT METHADONE-TREATED PATIENTS. RESULTS OF A RANDOMIZED PILOT STUDY
  af: GONZALEZ, G.